Company intelligence / Profile preview

Enovate Biolife

Wilmington, Delaware, United Statesenovatebiolife.com ↗

Ownership: Private
Development stage: Commercial

Overview

Enovate Biolife’s key ingredients—such as Lanconone®, Oxyjun®, and enXtra—are supported by multiple human clinical studies demonstrating efficacy in their respective indications. These ingredients have won industry awards and are used globally by supplement brands.

Therapeutic areas: Men's HealthOtherRheumatologyGastroenterologyCardiovascularNeurology
Modalities: Botanical extractPlant-based ingredient
Industry: Food & Nutrition

Drug pipeline

3 assets

enXtra

Commercial

Indications: Mental energy

2 more assets in the full pipeline.

Request access →

Partnerships

OmniActive Health Technologies (before acquisition)Global licensing agreements for distribution of key ingredients like enXtra®Univar Solutions (distribution partnerships)

Beyond the preview

Go deeper on Enovate Biolife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enovate Biolife.

Explore the full profile